Personalis Inc.

13.99-0.5200-3.58%Vol 461.31K1Y Perf -46.25%
Nov 26th, 2021 13:00 DELAYED
BID13.99 ASK14.02
Open14.15 Previous Close14.51
Pre-Market- After-Market-
 - -%  - -
Target Price
32.00 
Analyst Rating
Moderate Buy 2.00
Potential %
128.74 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     52.68
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+     54.46
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
1.47 
Earnings Rating
Market Cap626.53M 
Earnings Date
4th Nov 2021
Alpha-0.02 Standard Deviation0.19
Beta1.45 

Today's Price Range

13.8814.59

52W Range

13.4053.46

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-6.42%
1 Month
-24.62%
3 Months
-32.05%
6 Months
-37.15%
1 Year
-46.25%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
PSNL13.99-0.5200-3.58
AAPL156.81-5.1300-3.17
GOOG2 856.12-78.2300-2.67
MSFT329.68-8.2300-2.44
XOM61.25-2.2300-3.51
WFC48.43-2.8800-5.61
JNJ159.20-1.0400-0.65
FB333.12-7.9400-2.33
GE97.84-4.3900-4.29
JPM161.93-5.0300-3.01
Earnings HistoryEstimateReportedSurprise %
Q03 2021-0.40-0.400.00
Q02 2021-0.39-0.3412.82
Q01 2021-0.37-0.2921.62
Q04 2020-0.30-0.34-13.33
Q03 2020-0.30-0.2710.00
Q02 2020-0.34-0.2914.71
Q01 2020-0.26-0.29-11.54
Q04 2019-0.26-0.2119.23
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.40
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume461.31K
Shares Outstanding44.78M
Shares Float29.40M
Trades Count3.90K
Dollar Volume6.93M
Avg. Volume651.92K
Avg. Weekly Volume455.05K
Avg. Monthly Volume406.65K
Avg. Quarterly Volume377.80K

Personalis Inc. (NASDAQ: PSNL) stock closed at 13.99 per share at the end of the most recent trading day (a -3.58% change compared to the prior day closing price) with a volume of 461.31K shares and market capitalization of 626.53M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 235 people. Personalis Inc. CEO is John West.

The one-year performance of Personalis Inc. stock is -46.25%, while year-to-date (YTD) performance is -61.79%. PSNL stock has a five-year performance of %. Its 52-week range is between 13.4 and 53.46, which gives PSNL stock a 52-week price range ratio of 1.47%

Personalis Inc. currently has a PE ratio of -10.80, a price-to-book (PB) ratio of 2.06, a price-to-sale (PS) ratio of 7.42, a price to cashflow ratio of 103.80, a PEG ratio of 2.32, a ROA of -17.90%, a ROC of -19.52% and a ROE of -22.18%. The company’s profit margin is -69.34%, its EBITDA margin is -61.60%, and its revenue ttm is $84.99 Million , which makes it $1.90 revenue per share.

Of the last four earnings reports from Personalis Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.40 for the next earnings report. Personalis Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Personalis Inc. is Moderate Buy (2), with a target price of $32, which is +128.74% compared to the current price. The earnings rating for Personalis Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Personalis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Personalis Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 26.02, ATR14 : 1.13, CCI20 : -114.47, Chaikin Money Flow : -0.23, MACD : -1.46, Money Flow Index : 15.01, ROC : -26.17, RSI : 28.34, STOCH (14,3) : 7.59, STOCH RSI : 0.37, UO : 30.98, Williams %R : -92.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Personalis Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (50.00 %)
3 (50.00 %)
5 (71.43 %)
Moderate Buy
0 (0.00 %)
2 (33.33 %)
1 (14.29 %)
Hold
3 (50.00 %)
1 (16.67 %)
1 (14.29 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Strong Buy
1.58
Strong Buy
1.36

Personalis Inc.

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services.

CEO: John West

Telephone: +1 650 752-1300

Address: 1330 O'Brien Drive, Menlo Park 94025, CA, US

Number of employees: 235

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

56%44%

Bearish Bullish

52%48%

News

Stocktwits